The DOI matches its OpenAlex record; 1 of the 1 references it cites were found in a registry or an index.
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions
Open accessAbstract
Diabetes in humans accelerates cardiovascular disease caused by atherosclerosis. The relative contributions of hyperglycemia and dyslipidemia to atherosclerosis in patients with diabetes are not clear, largely because there is a lack of suitable animal models. We therefore have developed a transgenic mouse model that closely mimics atherosclerosis in humans with type 1 diabetes by breeding low-density lipoprotein receptor-deficient mice with transgenic mice in which type 1 diabetes can be induced at will. These mice express a viral protein under control of the insulin promoter and, when infected by the virus, develop an autoimmune attack on the insulin-producing beta cells and subsequently develop type 1 diabetes. When these mice are fed a cholesterol-free diet, diabetes, in the absence of associated lipid abnormalities, causes both accelerated lesion initiation and increased arterial macrophage accumulation. When diabetic mice are fed cholesterol-rich diets, on the other hand, they develop severe hypertriglyceridemia and advanced lesions, characterized by extensive intralesional hemorrhage. This progression to advanced lesions is largely dependent on diabetes-induced dyslipidemia, because hyperlipidemic diabetic and nondiabetic mice with similar plasma cholesterol levels show a similar extent of atherosclerosis. Thus, diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schleicher, E. D., Wagner, E., & Nerlich, A. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119180 · Cited by 714
Research works printed but not linked: 39
- 10.1001/jama.241.19.2035 · DOI · Paper page
- 10.1016/0092-8674(91)90165-U · DOI · Paper page
- 10.1016/0092-8674(91)90164-T · DOI · Paper page
- 10.1016/1074-7613(94)90101-5 · DOI · Paper page
- 10.1172/JCI117179 · DOI · Paper page
- Pichler, 2003, J. Am. Soc. Nephrol., 14, 124A
- 10.1172/JCI118604 · DOI · Paper page
- 10.1038/2012 · DOI · Paper page
- 10.2337/diabetes.49.6.1064 · DOI
- 10.2337/diabetes.50.7.1654 · DOI · Paper page
- Dixon, 1999, Arterioscler. Thromb. Vasc. Biol., 19, 2981, 10.1161/01.ATV.19.12.2981 · DOI
- Reaven, 1997, Arterioscler. Thromb. Vasc. Biol., 17, 2250, 10.1161/01.ATV.17.10.2250 · DOI
- 10.1161/01.CIR.0000124061.78478.94 · DOI · Paper page
- Williams, 1998, Curr. Opin. Lipidol., 9, 471, 10.1097/00041433-199810000-00012 · DOI · Paper page
- Cuff, 2001, J. Clin. Invest., 108, 1031, 10.1172/JCI200112455 · doi:10.1172/jci200112455 · Paper page
- Horiuchi, 1996, Diabetes., 45(Suppl. 3), S73, 10.2337/diab.45.3.S73 · DOI
- 10.1074/jbc.M006545200 · DOI · Paper page
- Januszewski, 2003, Biochem. Soc. Trans., 31, 1413, 10.1042/bst0311413 · DOI
- Kislinger, 2001, Arterioscler. Thromb. Vasc. Biol., 21, 905, 10.1161/01.ATV.21.6.905 · DOI · Paper page
- 10.2337/diabetes.51.5.1556 · DOI
- Virmani, 2000, Arterioscler. Thromb. Vasc. Biol., 20, 1262, 10.1161/01.ATV.20.5.1262 · DOI · Paper page
- Rosenfeld, 2000, Arterioscler. Thromb. Vasc. Biol., 20, 2587, 10.1161/01.ATV.20.12.2587 · DOI · Paper page
- 10.1161/01.ATV.0000014587.66321.B4 · DOI · Paper page
- 10.1161/01.ATV.0000060200.73623.F8 · DOI
- 10.2741/1190 · DOI
- 10.1016/S0002-8703(98)70144-9 · DOI
- 10.1056/NEJMoa035655 · DOI · Paper page
- 10.1016/S0021-9150(99)00479-7 · DOI · Paper page
- Moreno, 2000, Circulation., 102, 2180, 10.1161/01.CIR.102.18.2180 · DOI · Paper page
- 10.2337/diacare.14.9.839 · DOI · Paper page
- 10.2165/00003495-200060050-00001 · DOI
- Merat, 1999, Arterioscler. Thromb. Vasc. Biol., 19, 1223, 10.1161/01.ATV.19.5.1223 · DOI · Paper page
- Garber, 2000, J. Lipid Res., 41, 1020, 10.1016/S0022-2275(20)32045-9 · DOI
- Crawford, 1998, Arterioscler. Thromb. Vasc. Biol., 18, 1506, 10.1161/01.ATV.18.9.1506 · DOI
- Arnqvist, 1987, Clin. Chem., 33, 93, 10.1093/clinchem/33.1.93 · DOI
- Movat, 1955, Arch. Pathol., 60, 289
- 10.1021/bi00034a021 · DOI · Paper page
- 10.1007/s00125-003-1247-9 · DOI
- 10.2337/diabetes.50.4.851 · DOI · Paper page
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Immune and Inflammatory Mechanisms of Atherosclerosis
Galkina, E., & Ley, K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132620 · Cited by 1,437
Low Wang, C. C., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,155
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Bornfeldt, K. E., & Tabas, I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.07.015 · Cited by 995
Self-citationAnimal Models of Atherosclerosis
Getz, G. S., & Reardon, C. A. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.237693 · Cited by 630
Metadata
- Authors
- Renard, C. B., Kramer, F., Johansson, F., Lamharzi, N., Tannock, L. R., von Herrath, M. G., Chait, A., & Bornfeldt, K.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-09-01
- Volume
- 114
- Issue
- 5
- Pages
- 659-668
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2082913643
- Cited by
- 228
- References
- 1
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. https://app.cochat.ai/papers/10.1172/jci17867
- The paper
- Renard, C. B., Kramer, F., Johansson, F., Lamharzi, N., Tannock, L. R., von Herrath, M. G., Chait, A., & Bornfeldt, K. (2004). Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. Journal of Clinical Investigation. https://doi.org/10.1172/jci17867
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.